Kiora Pharmaceuticals
PublicKiora Pharmaceuticals is now publicly traded
The data on this page reflects Kiora Pharmaceuticals's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Private Placement
Apr 6, 2026
Total Funding Raised
$36.59M
Company Overview
Kiora Pharmaceuticals is based in ENCINITAS. It has raised $36.59M.
Kiora Pharmaceuticals is a clinical-stage biopharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases.
AI Layer
Non-AI
Kiora Pharmaceuticals Comparables
Compare Kiora Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanoscope Therapeutics Inc. | 82% | |
| Ray Therapeutics | 79% | |
| Restore Vision Inc. | 76% |
For institutional investors. Book with your work email.
Kiora Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Apr 6, 2026 | ||||
| Private Placement | Feb 5, 2024 | ||||
| Private Placement | Feb 3, 2023 | ||||
| Private Placement | Aug 9, 2021 | ||||
| Private Placement | Oct 2, 2019 | ||||
Private Placement | Jun 30, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Kiora Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ADAR1 Capital Management | Private Placement |
| Velan Capital | Private Placement |
| Perceptive Advisors | Private Placement |
| Rosalind Advisors | Private Placement |
| Stonepine Capital Management | Private Placement |
| Nantahala Capital Management | Private Placement |
Kiora Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.